特定情况下交易终止 Organon & Co将向太阳制药美国控股支付1.2亿美元解约费

美股速递
Apr 27

根据最新提交至美国证券交易委员会的文件披露,若在特定情形下交易协议被终止,Organon & Co将需要向Sun Pharmaceutical Holdings USA支付高达1.2亿美元的终止费用。

该条款明确了交易双方在意外情况下的责任归属,展现出合作协议中对风险管控的重视。这笔巨额解约费的设定,既体现了交易价值的重要性,也为可能出现的变数提供了明确的解决方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10